Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies.

Ito D, Frantz AM, Williams C, Thomas R, Burnett RC, Avery AC, Breen M, Mason NJ, O'Brien TD, Modiano JF.

Leuk Lymphoma. 2012 Jul;53(7):1390-8. doi: 10.3109/10428194.2011.654337. Epub 2012 Feb 3.

3.

[Effect of CD(40) on the in vitro biological behavior of malignant B lymphocytes].

Shi H, Qi C, Zhuang Y, Gu Z, Yu G, Zhao W, Zhang X.

Zhonghua Xue Ye Xue Za Zhi. 2002 Aug;23(8):420-4. Chinese.

PMID:
12411046
4.

CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphoma.

Burington B, Yue P, Shi X, Advani R, Lau JT, Tan J, Stinson S, Stinson J, Januario T, de Vos S, Ansell S, Forero-Torres A, Fedorowicz G, Yang TT, Elkins K, Du C, Mohan S, Yu N, Modrusan Z, Seshagiri S, Yu SF, Pandita A, Koeppen H, French D, Polson AG, Offringa R, Whiting N, Ebens A, Dornan D.

Sci Transl Med. 2011 Mar 16;3(74):74ra22. doi: 10.1126/scitranslmed.3001620.

5.

Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo.

Wu Y, Wang L, He X, Xu H, Zhou L, Zhao F, Zhang Y.

Cell Immunol. 2008 May-Jun;253(1-2):102-9. doi: 10.1016/j.cellimm.2008.05.005. Epub 2008 Jul 7.

PMID:
18603231
6.

Generation of human CD40-activated B cells.

Liebig TM, Fiedler A, Zoghi S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon MS.

J Vis Exp. 2009 Oct 16;(32). pii: 1373. doi: 10.3791/1373.

7.

Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.

Kedar R, Sabag O, Licthenstein M, Lorberboum-Galski H.

Cancer. 2012 Dec 15;118(24):6089-104. doi: 10.1002/cncr.27654. Epub 2012 Jun 12.

8.

Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation.

Mueller CG, Boix C, Kwan WH, Daussy C, Fournier E, Fridman WH, Molina TJ.

J Leukoc Biol. 2007 Sep;82(3):567-75. Epub 2007 Jun 15.

PMID:
17575267
9.

[Inhibition of human glioma cell growth by a soluble recombinant human CD40 ligand].

Gao YL, Shi HZ, Liu M, Gu XS.

Ai Zheng. 2002 Oct;21(10):1112-5. Chinese.

PMID:
12508655
10.

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

Buske C, Gogowski G, Schreiber K, Rave-Fränk M, Hiddemann W, Wörmann B.

Exp Hematol. 1997 Apr;25(4):329-37.

PMID:
9131008
11.

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.

Shringarpure R, Catley L, Bhole D, Burger R, Podar K, Tai YT, Kessler B, Galardy P, Ploegh H, Tassone P, Hideshima T, Mitsiades C, Munshi NC, Chauhan D, Anderson KC.

Br J Haematol. 2006 Jul;134(2):145-56.

PMID:
16846475
12.

In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.

Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG, Hiddemann W, Wörmann B.

Leukemia. 1997 Nov;11(11):1862-7.

PMID:
9369419
13.

Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.

Szocinski JL, Khaled AR, Hixon J, Halverson D, Funakoshi S, Fanslow WC, Boyd A, Taub DD, Durum SK, Siegall CB, Longo DL, Murphy WJ.

Blood. 2002 Jul 1;100(1):217-23.

14.

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.

Guan H, Xie L, Leithäuser F, Flossbach L, Möller P, Wirth T, Ushmorov A.

Blood. 2010 Sep 2;116(9):1469-78. doi: 10.1182/blood-2009-12-256446. Epub 2010 Jun 2.

15.

Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.

Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, Ohtake T, Takenoshita S, Abe M.

Mod Pathol. 2005 Mar;18(3):398-405.

16.

Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth.

Pizzi M, Piazza F, Agostinelli C, Fuligni F, Benvenuti P, Mandato E, Casellato A, Rugge M, Semenzato G, Pileri SA.

Oncotarget. 2015 Mar 30;6(9):6544-52.

17.

Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.

Strömberg T, Feng X, Delforoush M, Berglund M, Lin Y, Axelson M, Larsson O, Georgii-Hemming P, Lennartsson J, Enblad G.

Med Oncol. 2015 Jul;32(7):188. doi: 10.1007/s12032-015-0630-y. Epub 2015 May 29.

PMID:
26021470
18.

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M, Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt LM.

J Exp Med. 2003 Sep 15;198(6):851-62.

19.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM.

Nature. 2000 Feb 3;403(6769):503-11.

PMID:
10676951
20.

Cell enrichment-free massive ex-vivo expansion of peripheral CD20⁺ B cells via CD40-CD40L signals in non-human primates.

Kim JS, Byun N, Chung H, Kim HJ, Kim JM, Chun T, Lee WW, Park CG.

Biochem Biophys Res Commun. 2016 Apr 22;473(1):92-8. doi: 10.1016/j.bbrc.2016.03.057. Epub 2016 Mar 16.

PMID:
26993166

Supplemental Content

Support Center